Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Psychopharmacology (Berl) ; 235(12): 3415-3422, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30283981

ABSTRACT

RATIONALE: Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis has been widely reported in depression, and evidence suggests that selective serotonin reuptake inhibitors (SSRIs) might exert their therapeutic effects through altering cortisol secretion. OBJECTIVE: This study assessed the effects of SSRI administration on diurnal cortisol secretion in healthy volunteers. METHODS: Sixty-four healthy men and women were randomised to receive either 10 mg escitalopram or placebo for six days in a double-blind fashion. On day six of medication, saliva samples were obtained at home for measurement of diurnal cortisol parameters (cortisol slope, cortisol awakening response, total daily cortisol output). RESULTS: Women receiving escitalopram had significantly steeper cortisol slopes across the day compared with those receiving placebo (F(1, 36) = 7.54, p = 0.009). This alteration in cortisol slope was driven by increases in waking cortisol levels (F(1, 35) = 9.21, p = 0.005). Escitalopram did not have any significant effect on the cortisol awakening response or the total daily cortisol output. CONCLUSIONS: Flattened cortisol slopes have been seen in depression. The results of this study suggest that escitalopram might exert its therapeutic effect in women in part through correction of a flattened diurnal cortisol rhythm.


Subject(s)
Circadian Rhythm/physiology , Citalopram/administration & dosage , Hydrocortisone/metabolism , Selective Serotonin Reuptake Inhibitors/administration & dosage , Adult , Circadian Rhythm/drug effects , Double-Blind Method , Female , Healthy Volunteers , Humans , Hypothalamo-Hypophyseal System/drug effects , Hypothalamo-Hypophyseal System/metabolism , Male , Pituitary-Adrenal System/drug effects , Pituitary-Adrenal System/metabolism , Saliva/drug effects , Saliva/metabolism , Young Adult
2.
Brain Behav Immun ; 70: 369-375, 2018 05.
Article in English | MEDLINE | ID: mdl-29588232

ABSTRACT

Acute mental stress elicits increases in plasma cytokine concentrations in humans, but the underlying mechanisms remain poorly understood. We assessed the impact of beta-adrenergic blockade on plasma interleukin 6 (IL-6) and IL-1 receptor antagonist (IL-1Ra) responses in a parallel group, double-blind randomised placebo-controlled trial involving 64 healthy young adult volunteers. Participants were administered 80 mg slow-release propranolol or placebo daily for 7 days before the stress testing session in which responses to 3 behavioural challenges (public speaking, mirror tracing, mental arithmetic) were evaluated. Propranolol administration was associated with reduced baseline levels of heart rate and IL-1Ra, and systolic blood pressure (BP) in men. Tasks stimulated increased plasma IL-6 concentrations sampled 45 min and 75 min after challenge, but these responses were blocked by propranolol in men (p < 0.001). Propranolol did not influence IL-6 responses in women, or IL-1Ra in either sex. Blood pressure and heart rate increased markedly during the tasks, but there was no differential stress reactivity in propranolol and placebo conditions. The results of the study support a role of sympathetic nervous system activation in stimulating acute IL-6 responses to stress, but only in men. The reasons for the differences between men and women remain to be resolved.


Subject(s)
Adrenergic beta-Antagonists/metabolism , Cardiovascular System/drug effects , Stress, Psychological/metabolism , Adrenergic beta-Antagonists/pharmacology , Adult , Blood Pressure , Cardiovascular System/metabolism , Double-Blind Method , Exercise Test , Female , Healthy Volunteers , Heart Rate , Humans , Inflammation , Interleukin-1/analysis , Interleukin-1/blood , Interleukin-6/analysis , Interleukin-6/blood , Male , Placebo Effect , Propranolol/pharmacology , Stress, Psychological/drug therapy , Sympathetic Nervous System/drug effects , Young Adult
3.
Psychoneuroendocrinology ; 51: 209-18, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25462894

ABSTRACT

Psychological stress may contribute to type 2 diabetes but mechanisms are still poorly understood. In this study, we examined whether stress responsiveness is associated with glucocorticoid and mineralocorticoid sensitivity in a controlled experimental comparison of people with type 2 diabetes and non-diabetic participants. Thirty-seven diabetes patients and 37 healthy controls underwent psychophysiological stress testing. Glucocorticoid (GR) and mineralocorticoid sensitivity (MR) sensitivity were measured by dexamethasone- and prednisolone-inhibition of lipopolysaccharide (LPS)-induced interleukin (IL) 6 levels, respectively. Blood pressure (BP) and heart rate were monitored continuously, and we periodically assessed salivary cortisol, plasma IL-6 and monocyte chemotactic protein (MCP-1). Following stress, both glucocorticoid and mineralocorticoid sensitivity decreased among healthy controls, but did not change in people with diabetes. There was a main effect of group on dexamethasone (F(1,74)=6.852, p=0.013) and prednisolone (F(1,74)=7.295, p=0.010) sensitivity following stress at 45 min after tasks. People with diabetes showed blunted stress responsivity in systolic BP, diastolic BP, heart rate, IL-6, MCP-1, and impaired post-stress recovery in heart rate. People with Diabetes had higher cortisol levels as measured by the total amount excreted over the day and increased glucocorticoid sensitivity at baseline. Our study suggests that impaired stress responsivity in type-2 diabetes is in part due to a lack of stress-induced changes in mineralocorticoid and glucocorticoid sensitivity.


Subject(s)
Diabetes Mellitus, Type 2/physiopathology , Hypothalamo-Hypophyseal System/drug effects , Interleukin-6/blood , Pituitary-Adrenal System/drug effects , Stress, Psychological/physiopathology , Aged , Blood Pressure/drug effects , Chemokine CCL2/blood , Dexamethasone/pharmacology , Diabetes Mellitus, Type 2/blood , Female , Glucocorticoids/pharmacology , Heart Rate/drug effects , Humans , Hydrocortisone/analysis , Hypothalamo-Hypophyseal System/physiopathology , Male , Middle Aged , Pituitary-Adrenal System/physiopathology , Prednisolone/pharmacology , Saliva/chemistry , Stress, Psychological/blood
4.
Obesity (Silver Spring) ; 20(10): 2113-7, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22402739

ABSTRACT

Pericardial fat is emerging as a unique risk factor for coronary disease. We examined the relationship between objectively measured physical activity during free-living and pericardial fat. Participants were 446 healthy men and women (mean age = 66 ± 6 years), without history or objective signs of cardiovascular disease (CVD), drawn from the Whitehall II epidemiological cohort. Physical activity was objectively measured using accelerometers (Actigraph GT3X) worn around the hip during waking hours for 7 consecutive days (average daily wear time = 889 ± 68 min/day), and was classified as sedentary (<200 counts/min (cpm)), light (200-1,998 cpm), or moderate-vigorous physical activity (MVPA; ≥1,999 cpm). Pericardial fat volume was measured in each participant using electron beam computed tomography. Average daily cpm in men was 338.0 ± 145.0 and in women 303.8 ± 130.2. There was an inverse association between average cpm and pericardial fat (B = -0.070, 95% confidence interval (CI), -0.101, -0.040, P < 0.001), and this remained significant after adjusting for age, sex, registered wear time, BMI, lipids, glycemic control, blood pressure, smoking, statins, and social status. Both sedentary time (B = 0.081, 95% CI, 0.022, 0.14) and MVPA (B = -0.362, 95% CI, -0.527, -0.197) were also associated with pericardial fat, although associations for sedentary time did not remain significant after adjustment for MVPA. The inverse association between physical activity and pericardial fat was stronger among overweight and obese adults than in normal weight. Objectively assessed daily activity levels are related to pericardial fat in healthy participants, independently of BMI. This might be an important mechanism in explaining the association between physical activity and CVD prevention.


Subject(s)
Adipose Tissue , Coronary Artery Disease/prevention & control , Motor Activity , Pericardium , Sedentary Behavior , Activities of Daily Living , Aged , Blood Glucose/metabolism , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/epidemiology , Female , Humans , Male , Obesity/complications , Obesity/epidemiology , Pericardium/diagnostic imaging , Risk Factors , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...